Characteristics of children surviving to 5 years of age or older with vertically acquired HIV infection.
Mark W. Kline(Tulane University), William T. Shearer(Baylor College of Medicine), Claudia A. Kozinetz(Feminist Archive North), Mary E. Paul(Texas Children's Hospital), Beverly Bohannon(Veterans Health Administration)
PubMed
December 1, 1995
Cited by 20
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Viral Load and Disease Progression in Infants Infected with Human Immunodeficiency Virus Type 1
|New England Journal of Medicine|1997|551
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experience
|Journal of Allergy and Clinical Immunology|2013|343
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
|Journal of Allergy and Clinical Immunology|2017|318